Below is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you.
White House insider Jim Rickards just went public with all the details of Trump’s secret plan for America’s 250th anniversary…
And he will even show you a public hand-written letter from President Trump himself….
That proves something HUGE is happening this coming May.
In fact, the Financial Times estimates this new Trump move could help unleash $100 trillion in new wealth.
And legendary trader Paul Tudor Jones, who became famous after he had five consecutive years of 100%+ returns.
Your interaction with our content, in any format, is appreciated. We value your time and the trust you place in our communications. Thank you for being an active member of our community, and we look forward to continued exchanges in the future. Privacy Policy InsiderTrades.com ("the Company") values the privacy of visitors to InsiderTrades.com site and users of our services. This notice explains how we collect, use, and protect information. Why You're Receiving This Email You're receiving this email because at some point, you opted in to receive updates, news, or information on a specific topic we've previously discussed or shared. Whether it was through a subscription, a form submission, or another form of communication, your information was shared willingly, and we respect your decision to connect with us. Thank you for taking the time to read this email. This message is part of an ongoing conversation between us, and I want to take a moment to ensure you have full transparency about why you received this message, how your information is handled, and what to expect from future emails. If you're wondering about the nature of our correspondence, rest assured that we aim to keep all emails relevant, timely, and from unnecessary clutter. This includes respecting your inbox and refraining from sending irrelevant messages. A Commitment to Non-Intrusive Emails We aim to create a non-intrusive communication experience. This means we won't overwhelm your inbox with excessive messages, and we work hard to ensure our content remains clear and concise. The purpose of this email is to stay connected with you and provide updates or information that we believe is meaningful. If we ever fail to meet these standards, we encourage you to let us know. Feedback, whether positive or constructive, is always appreciated. Your thoughts help us understand how we can do better and improve our communication approach. While we cannot promise every suggestion will be implemented, we will take the time to carefully review and consider your input. Accessibility and Communication If you have any trouble accessing the unsubscribe page, managing preferences, or understanding why you're receiving this email, you can reach out directly to our support team. We aim to provide a response within a reasonable time frame and address your concerns effectively. Our communication is designed to be as inclusive as possible, but we know there's always room for improvement. If you have any feedback on how we can make our emails more accessible or relevant, please don't hesitate to share. Your Privacy is Important We value your trust and take your privacy very seriously. The information you provide is securely stored and never shared, sold, or used outside the purpose for which you provided it. This privacy policy describes how we collects, uses, and protects your information. We collect information you voluntarily provide, such as your name, email address, or phone number. We may also collect technical data from your visit, including browser type, operating system, and your IP address. We use this information to respond to your inquiries, provide access to services, and improve our communications. We do not share your information with unrelated third parties. Some of our services may use third-party tools that store or process data on our behalf. These tools are selected with care and are expected to maintain data responsibly. We do not knowingly collect personal information from children under 13 years of age. If we discover that such information was provided without parental consent, we will delete it promptly. You can request to update or delete your personal information by contacting us. We may update this privacy policy occasionally. Changes will be reflected on the page. Orders with InsiderTrades.com are handled using secure processes. If there is a need to update delivery details, someone from our team may contact you. Please note, we do not ask for personal payment information by email. You can enable extra sign-in protection and use strong security to help keep you safe. We regularly review our systems and follow best practices to help protect your information. If you notice anything unusual, it may be helpful to review your settings. Transparency is our priority, and we're happy to address any questions you might have. How to Unsubscribe or Manage Your Preferences We understand that everyone's inbox is different. If you ever find our emails no longer relevant, there's no hard feelings. You can easily manage your email preferences or unsubscribe using the link provided below. By clicking the unsubscribe link, you'll be taken to a page where you can either adjust your communication preferences (such as receiving fewer emails or only on specific topics) or completely remove yourself from our list. The process is straightforward, and any changes will take effect promptly. We don't use tricks or gimmicks to keep you subscribed. Our priority is to ensure that our emails add value to your day, and if they don't, we respect your decision to part ways. Legal Information We comply with all applicable laws and regulations regarding email communication. This includes adhering to laws and maintaining the highest standards for consent-based communication. Your trust matters, and we work diligently to ensure every email you receive meets these requirements. If you need further clarification on our compliance policies or legal obligations, please ask. Transparency and accountability are central to our communication strategy, and we're happy to provide additional details if needed. Contact Information We strive to ensure all communication channels are open and readily available to you. Whether it's a question, comment, or concern, our team is ready to assist. For assistance, please contact our team via email by replying to this email. A Final Note Emails are one of the many ways we stay connected, but we understand they aren't perfect for everyone. If there's another way you'd prefer to communicate or stay updated, let us know. Whether it's through social media, a direct call, or another channel, we're open to finding the most effective way to share information with you. We want to emphasize that our goal is never to disrupt or clutter your inbox. Every email sent is intended to provide value, and we genuinely appreciate your time and attention. This footer was designed to ensure transparency, provide essential information, and give you full control over your communication preferences. We hope it meets your expectations, but if there's anything you'd like to see improved, we're always here to listen. Best regards, InsiderTrades.com
This Month's Exclusive Story
Is Abbott's January Pullback a Good Time to Buy?
Submitted by Thomas Hughes. First Published: 1/24/2026.
What You Need to Know
- Abbott Laboratories’ January pullback looks driven more by sentiment than fundamentals, putting shares back near a prior accumulation zone.
- Quarterly results showed solid sales growth, improving margins, and faster adjusted earnings growth despite a revenue miss.
- A long dividend-growth track record and potential upside implied by analyst targets underpin the bullish rebound case.
Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making the stock look more attractively valued. The move, driven more by market angst than by underlying weakness, appears to be a knee-jerk overreaction that has pushed the shares back into a buy zone.
The former CEO of Google calls it the most important thing to happen in 500, maybe 1,000 years of human society. A former U.S. Treasury Secretary says when your great-grandchildren write the history of this period, the political headlines will be the second or third story. The first story is something none of us have seen before. The dot-com collapse, global financial crisis, and COVID-19 pandemic don't compare to what's coming next. We may be entering a period of dramatic, almost unimaginable change.
See the full warning and how to prepare now.
The zone in question aligns with price action from 2022–2024, when Abbott was recovering from a post‑COVID revenue contraction and institutions were actively accumulating the stock.
Abbott Laboratories Growth Accelerates
While some metrics in Abbott's Q4 results and guidance fell short of expectations, the overall picture showed progress: revenue of $11.46 billion (+4.5% year‑over‑year), improved margins, and accelerated adjusted earnings growth.
Revenue growth missed by several hundred basis points, but margin strength helped offset that shortfall—adjusted earnings per share (EPS) rose about 12%, slightly above consensus.
Segment-level results highlighted the strength of Abbott's diversified healthcare portfolio. Nutrition and Diagnostics contracted—Nutrition declined nearly 9%—but that weakness was offset by robust growth in Established Pharmaceuticals and Med Tech.
Established Pharmaceuticals grew roughly 9%, helped by generics and emerging markets, while Med Tech expanded about 12.3% with broad strength across its sub-segments.
Margins improved due to a favorable product mix, strength in Med Tech, lower COVID‑19-related sales and operational improvements. While some analysts had hoped for even larger margin expansion, margins are healthier year over year and management expects continued progress.
Looking ahead, management forecasts roughly 10% EPS growth in 2026—outpacing revenue growth—and believes that performance will support its capital-return plans.
Abbott's capital returns are central to the investment thesis. The company is a Dividend King, having raised its dividend for more than 50 consecutive years, and it appears positioned to continue that track record. After the pullback, the stock yields about 2.5%, and the company currently pays out less than half of consensus EPS—leaving room for continued share buybacks, which help offset dilution from share-based compensation.
Analysts Point to Robust Rebound in Abbott Laboratories Stock
Some analysts noted the revenue miss, but there were no major rating or price-target cuts the morning of the earnings release. The prevailing view is that Abbott remains fundamentally healthy and can continue returning capital while reinvesting for growth.
MarketBeat's consensus share price target implies up to roughly 30% upside—potentially to new all‑time highs—while even low‑end targets suggest some upside from current levels.
Key catalysts include an expanding Med Tech portfolio, greater AI integration across operations and products, widening margins, and strategic acquisitions. The acquisition of Exact Sciences, for example, broadens Abbott's revenue and profit streams and its product pipeline.
That said, the decline in the stock has been sharp and further downside is possible. Institutions were net buyers throughout 2025 and are likely to add at discounted prices. There is tentative support in the $105–$110 range, though it is unconfirmed. Shares could still drop to the low end of the buy zone—near $95 or lower—before a sustained rebound.
Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO's, CFO's, COO's and other insiders.
This email message is a sponsored message from Paradigm Press, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you have questions about your account, don't hesitate to contact our U.S. based support team at
contact@marketbeat.com.
If you no longer wish to receive email from InsiderTrades.com, you can
unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place, Suite 620, Sioux Falls, S.D. 57103-7078. USA.
.
Daily Bonus Content: The day the gold market broke (From Behind the Markets)
